Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 191-198

  Hayashi, Kazuhiko ^a   Chen, Wen Gang ^a   Chen, Yuan Yuan ^a   Murakami, Ichiro ^b   Chen, Hong Li ^c   Ohara, Nobuya ^c   Nose, Soichiro ^d   Hamaya, Kazuo ^d   Matsui, Satoshi ^e   Bacchi, Maura M ^f   Bacchi, Carlos E ^f   Chang, Karen L ^a   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b IWAKUNI NATIONAL HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d OKAYAMA SAISEIKAI GENERAL HOSPITAL   (Japan)

^e Jyugen General Hospital   (Japan)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BRAZIL; CANCER INCIDENCE; CANCER INVASION; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CARCINOMA; FEMALE; GENE DELETION; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; JAPAN; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 0031974404     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Anagnostopoulos I, Hummel M: Epstein-Barr virus in tumours. Histopathology 1996, 29:297-315
2. Weiss LM, Chang KL: Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv Anat Pathol 1996, 3:1-15
3. Osato T, Imai S: Epstein-Barr virus, and gastric carcinoma. Semin Cancer Biol 1966, 7:175-182
4. Burke AP, Yen TSB, Shekitka KM, Sobin LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990, 3:377-380
5. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM: Epstein-Barr viral sequences are commonly present in the carcinoma cells of gastric lymphoepithelioma-like carcinoma. Am J Pathol 1991, 139:1-5
6. Shibata D, Weiss LM: Epstein-Barr virus-associated gastric carcinoma. Am J Pathol 1992, 140:769-774
7. Tokunaga M, Land CE, Uenura Y, Tokudome T, Tanaka S, Sato E: Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993, 143:1250-1254
8. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994, 91:9131-9135
9. Ott G, Kirchner TH, Muller-Hermelink HK: Monoclonal Epstein-Barr virus genomes lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 1994, 25:323-329
10. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N: Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 1993, 143:1063-1071
11. Matsunou H, Konishi F, Hori H, Ikeda T, Sasaki K, Hirose Y, Yamamichi N: Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996, 77:1998-2004
12. Ohfuji S, Osaki M, Tsujitani S, Ikeguchi M, Sairenji T, Ito H: Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int J Cancer 1996, 68:710-715
13. Yamamoto N, Tokunaga M, Uemura Y, Tanaka S, Shirahama H, Nakamura T, Land CE, Sato E: Epstein-Barr virus and gastric remnant cancer Cancer 1994, 74:805-809
14. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K: Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994, 71:73-81
15. Yuen ST, Chung LP, Leung SY, Luk ISC, Chan SY, Ho J: In Situ detection of Epstein-Barr virus in gastric, and colorectal adenocarcinomas. Am J Surg Pathol 1994, 18:1158-1163
16. Selves J, Bibeau F, Brousset P, Meggetto F, Mazerolles C, Voight J-J, Pradere B, Chiotasso P, Delsol G: Epstein-Barr virus latent, and replicative gene expression in gastric carcinoma. Histopathology 1996, 28:121-127
17. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nonura A: Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer 1994, 60:642-644
18. Kida Y, Miyauchi K, Takano Y: Gastric adenocarcinoma with differenuation to sarcomatous components associated with monoclonal Epstein-Barr virus infection and LMP-1 expression. Virchows Arch A Pathol Anat Histopathol 1993, 423:383-387
19. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG: Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996, 27:20-27
20. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43:831-840
21. Kaye KM, Izumi KM, Kieff E: Epstein-Barr virus latent membrane protein1 is essential for B-lymphocyte growth transformation: Proc Natl Acad Sci USA 1993, 90:9150-9154
22. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65:1107-1115
23. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995, 80:389-399
24. Hu L-F, Zavarovsky ER, Chen F, Cao S-L, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72:2399-2409
25. Chen M-L, Tsai C-N, Liang C-L, Shu C-H, Hang C-R, Sulitzeanu D, Liu S-T, Chang Y-S: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7:2131-2140
26. Hu L-F, Chen F, Zheng X, Ernberg I, Cao S-L, Christensson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993, 8:1575-1583
27. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993, 82:2937-2942
28. Sandvej K, Peh S-C, Andresen BS, Pallesen G: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994, 84:4053-4060
29. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995, 10:523-528
30. Vasef MA, Kamel OW, Chen Y-Y, Medeiros LJ, Weiss LM: Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995, 147:1408-1415
31. Chen W-G, Chen Y-Y, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996, 148:17-23
32. Knecht H, Raphaël M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broët S, Bachmann E, Kershaw GR, Ryan S, Kitller ELW, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P: Deletion variants within the NF-kB activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphooroliferations. Blood 1996, 87:876-881
33. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlates with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996, 88:242-251
34. Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, Greiner TC: Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest 1996, 75: 575-588.
35. Khanim F, Yao Q-Y, Niedobitek G, Sihota S, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations Blood 1996, 88:3491-3501
36. Hayashi K, Chen W-G, Chen Y-Y, Bacchi MM, Bacchi CE, Alvarenga M, Abreu ES, Chang KL, Weiss LM: Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum Pathol 1997 (in press)
37. Cheung S-T, Lo K-W, Leung SF, Chan W-Y, Choi PHK, Johnson PJ, Lee JCK, Huang DP: Prevalence of LMP deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 1996, 66:711-712
38. Lin J-C, Lin S-C, De BK, Chan W-P, Evatt BL: Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993, 81:3372-3381
39. Sheibani K, Tubbs RR: Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol 1984, 1:235-250
40. Gown AM, deWever N, Battifora H: Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1984, 1:256-266
41. Weiss LM, Movahed LA, Chen Y-Y, Shin SS, Stroup RM, Bui N, Estess P, Bindl JM: Detection of immunoglobulin light-chain mRNA in lymphoid tissues using a practical in situ hybridization method. Am J Pathol 1990, 137:979-988
42. Chang KL, Chen Y-Y, Shibata D, Weiss LM: In situ hybridization methodology for the detection of EBV EBER-1 RNA in paraffin-embedded tissues, as applied to normal, and neoplastic tissues. Diagn Molec Pathol 1992, 1:246-255
43. Weiss LM, Chen Y-Y: Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J Histochem Cytochem 1991, 39: 1237-1242
44. Deamant FD, Albujar PF, Chen Y-Y, Weiss LM: Epstein-Barr virus distribution in nonneoplastic lymph nodes. Mod Pathol 1993, 6:729-732
45. Kieff E: Epstein-Barr virus and its replication. Fields Virology, ed 3. Edited by BN Fields. DM Knipe. PM Howley, RM Chanock, JL Melnick, TP Monath, B Roizman, SE Straus. Philadelphia, Lippincott-Raven, 1996, pp 2343-2396
46. Li S-N, Chang Y-S, Liu S-T: Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 1996, 12:2129-2135
47. Okan I, Wang Y, Chen F, Hu LF, Imreh S, Klein G, Wiman KG. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 1995, 11:1027-1031
48. Sugimura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T: Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996, 74:625-631
49. Chang Y-S, Su I-J, Chung P-J, Shu C-H, Ng C-K, Wu S-J, Liu S-T: Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995, 62:673-677
50. Sandvej K, Gratama JW, Munch M, Zhou X-G, Bolhuis RLH, Andresen BS, Gregersen N, Hamilton-Dutoit S: Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 1997, 90:323-330
51. Gratama JW, Ernberg I: Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 1995, 67:197-255
52. Qiu K, Tomita Y, Hashimoto M, Ohsawa M, Kawano K, Wu D-M, Aozasa K: Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype. Int J Cancer 1997, 71:155-158
53. Sidagis J, Ueno K, Tokunaga M, Ohyama M, Eizuru Y: Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies. Int J Cancer 1997, 72:72-76
54. Kunimoto M, Tamura S, Tabata T, Yoshie O: One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol 1992, 73:445-461